Your search for non small cell lung cancer returned 18 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Last 2 years remove
Drugs in the Pipeline remove

Your search for non small cell lung cancer returned 18 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Cemiplimab Granted Priority Review for Advanced NSCLC

Topline results from the trial showed that compared with chemotherapy, treatment with cemiplimab-rwlc reduced the risk of death by 32% in the overall trial population.